Conagra: The Freezer and the Fire

ISSUE 30 · MAY 29, 2026 · CAG $13.56

See the Investment Council's verdict on $CAG → Investment Council: CAG: pending →

All current verdicts: The Verdict Board →

In November 2024, Conagra Brands traded above $33. On May 29, 2026, it closed at $13.56. The 52-week high is $22.98. The 52-week low, set in April 2026, is $13.14. The stock has lost 41% from its 52-week high and more than 50% over five years. Market cap is approximately $6.5 billion. Enterprise value — including $7.3 billion in net debt — is roughly $13.8 billion.

The decline has three named causes and one structural one.

Named cause 1: A billion-dollar confession. In December 2025, Conagra reported Q2 FY26 results that included $968 million in non-cash goodwill and brand impairment charges — $771 million against the Refrigerated & Frozen segment's goodwill and $197 million in intangible asset write-downs. The trigger was the sustained decline in the company's share price and market capitalization. The GAAP result: a net loss of $664 million, or -$1.39 per share, against net income of $285 million in the year-ago quarter. The reported number is a 333% deterioration. The stock fell 2.6% post-earnings and Goldman Sachs downgraded to Sell.

The impairment is the accounting system catching up to the market. In 2018, Conagra acquired Pinnacle Foods — the parent of Birds Eye, Duncan Hines, Vlasic, and Wish-Bone — for $10.9 billion. That price assumed a portfolio of frozen and shelf-stable brands would grow into the premium the market was willing to pay. Eight years later, the goodwill generated by that premium is burning. The $968 million is the formal admission: Conagra overpaid.

Named cause 2: Five quarters of organic decline, then one quarter of inflection. From Q2 FY25 through Q2 FY26, Conagra posted negative or flat organic net sales every quarter. Volumes shrank across Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. Revenue fell 3.6% in FY25 and continued declining into FY26 Q1 and Q2. The Q2 FY26 print showed reported revenue of $2.98 billion, down 6.8% year-over-year, with organic sales declining 3%.

Then Q3 FY26 happened. Organic net sales grew +2.4% year-over-year. The frozen portfolio saw 88% of brands holding or gaining volume share. Snacks exceeded category growth for the fifth consecutive quarter. Refrigerated & Frozen shipments were +3.9%. This is the inflection the market hasn't priced in.

Named cause 3: Leverage and the tin-can problem. Conagra carries $7.3 billion in net debt at a 3.83x leverage ratio. Management has committed to $700 million in debt reduction during FY26, and the company's free cash flow conversion was raised to 105% — meaning it generates more free cash flow than net income. But the leverage is a structural overhang from Pinnacle, and the tariff environment is hostile. Conagra faces 7% cost-of-goods inflation — 4% from core food inflation (beef, chicken, pork, turkey, eggs all up double digits) and 3% from tariffs. The tariff exposure is concentrated in tin plate steel and aluminum, with a 50% tariff rate on imported materials used to make the cans that hold a third of the portfolio. Tariffs on food packaging are a Conagra-specific pain point that does not affect peers with primarily plastic or paperboard packaging.

The structural problem: A CEO who is leaving and a CEO who hasn't started. On April 13, 2026, Conagra announced that Sean Connolly, CEO for eleven years, will step down on May 31, 2026. His successor, John Brase — a 35-year consumer-goods veteran who was President and COO of J.M. Smucker and spent three decades at Procter & Gamble running a $6 billion North America Family Care business — takes over on June 1, 2026. That is two days from now. The market has had six weeks to digest the transition and has decided it doesn't care: the stock is lower today than on the day Brase was named.

That is how Conagra got to $13.

The company is not collapsing. Revenue has inflected. Margins are pressured but guided higher. Cash flow is healthy. The dividend is covered.

The story this table tells is not "broken company." It is "company with a leverage problem and a valuation problem running real operations that are actually improving." The frozen portfolio is gaining share. Snacks is outgrowing the category. Free cash flow is rising. The billion-dollar write-down was an accounting event, not an operational one. The same Birds Eye bags roll off the same production lines at the same margins.

The question is whether the improvement is fast enough to outrun the debt service and the inflation.

Conagra is a portfolio company. Consumers don't review "Conagra" — they review Banquet, Healthy Choice, Marie Callender's, Birds Eye, Slim Jim. The parent-company review pool is structurally thin. This is not a data gap; it is a category feature.

The per-channel floor for parent-company reviews does not meet the 100-review minimum for a powered two-proportion Z test. This is acknowledged. The statistical work operates on financial time series and competitive valuation data, where sample quality is higher.

The central analytical question for Conagra is not "is the consumer angry" (the parent-company review pool is too thin to say anything statistically) but rather: Is the Q3 FY26 organic growth inflection (+2.4%) a structural reversal or a promotional blip?

We observe 7 consecutive quarterly organic growth readings from Q1 FY25 through Q3 FY26. The first 5 show negative or flat organic growth. Q3 FY26 shows +2.4%. With only 7 quarterly observations, we cannot run a formal regime-change test.

Evidence that it's earned (structural): 88% of the frozen portfolio holding or gaining volume share — not a single-brand spike. Snacks outpacing the category for 5 consecutive quarters. Chef Boyardee divestiture ($607M) removed a declining brand, improving the organic base.

Evidence that it could be temporary: 7% COGS inflation has not yet fully flowed through to pricing. The 53rd-week tailwind in Q4 FY26 will artificially boost the next quarter. New CEO transitions historically correlate with 1-2 quarters of uncertainty.

Quantitative valuation gap. At 8.5x forward P/E, Conagra trades at a 34% discount to the food-staple peer average of 13.2x. The dividend yield of 10.3% is 2.5x the peer average of 4.1%. For the stock to merely re-rate to the peer average P/E, the price would need to reach ~$20.50 — a 51% upside from $13.56.

Finding: The organic inflection is supported by broad-based share gains across the frozen portfolio, but it is too early (one quarter) to declare structural. The valuation discount, however, is unambiguous: the market is pricing Conagra for permanent impairment, not for a company that just raised its free-cash-flow conversion forecast and is gaining share in its largest segment.

The impairment charges dominate the GAAP numbers, but they obscure what's actually happening inside the brands.

Marie Callender's chicken pot pie — once the frozen-aisle comfort-food default — has drawn sustained consumer complaints about shrinkflation and quality decline. Long-time customers report that prices have risen 50% while the pies shrank. Reddit threads recommended switching to Banquet's pot pie as a better alternative. This is a Conagra brand losing to a Conagra brand. The cannibalization is internal.

Banquet, meanwhile, has found an audience with its Mega Bowls line — the Dynamite Penne with Meatballs specifically has become a Reddit-recommended frozen meal. The value tier ($1-3 price point) is where Banquet competes, and in an inflationary environment, trading down is the consumer trend. Banquet's Mega Bowls are the beneficiary of the same inflation that's killing the premium frozen tier.

Healthy Choice maintains a loyal base — some customers report 15+ years of buying — but newer reviews surface quality complaints about undercooked vegetables and bland sauces. Birds Eye, acquired through Pinnacle, holds a leading position in frozen vegetables but doesn't generate the kind of consumer conversation that signals either love or revolt.

Slim Jim and Duke's are the quiet winners. The meat-snack category is growing faster than any other Conagra segment, and the company has been investing in protein-forward snack innovation that aligns with the macro trend toward protein snacking.

The brand story Conagra tells Wall Street — "we are a frozen and snacking company" — is partially true. The frozen business is recovering volume share. The snacking business is genuinely outperforming. But the frozen portfolio includes both brands that are gaining (Banquet Mega Bowls, Birds Eye) and brands that are being cannibalized or complained about (Marie Callender's). The aggregate 88% share-gain statistic hides the brand-level dispersion.

Glassdoor tells a parallel story. At 3.7 stars with 69% recommending and 51% having a positive outlook, Conagra's employee base is neither demoralized nor energized. The CEO transition has created uncertainty — reviews mention restructuring and staffing changes — but the overall tone is "stable company, not exciting, decent pay."

What IS recovering: Frozen volume share (88% of portfolio holding or gaining, Q3 FY26). Snack category outperformance (5th consecutive quarter). Debt reduction (net debt down $700M+ in FY26). Free cash flow (conversion raised to 105%). Portfolio focus (Chef Boyardee divested for $607M, frozen fish sold).

What is NOT recovering: GAAP earnings (-$1.39 EPS in Q2 due to impairment; adjusted EPS down 23.5% in Q3). Margin (7% COGS inflation only partially mitigated). Stock price (30-year lows despite operational improvement). Leverage (3.83x is elevated for food staples; peers run 2.5-3.0x).

What is UNKNOWN: Whether Brase's strategy will differ from Connolly's (he starts June 1). Whether tariff mitigation holds through FY27. Whether frozen share gains are sustainable post-promotional normalization. Whether the dividend will be cut (56% payout ratio is safe, but leverage creates tail risk).

The parent-company consumer review pool (292 reviews across Trustpilot, PissedConsumer, and Sitejabber) is insufficient to support a powered statistical test on consumer sentiment. Conagra is a holding company; its brands are reviewed at the product level, not the corporate level. The 1.6 Trustpilot rating is in-line with food-manufacturer peers (General Mills, Campbell's, Kraft Heinz all cluster between 1.5 and 2.1) and reflects complaint-platform self-selection, not representative consumer opinion.

The Q3 FY26 organic inflection (+2.4%) is a single quarter. Declaring a structural turn on one data point is premature. The 88% share-gain statistic in frozen is management-reported and not independently audited at the brand level.

The $968 million impairment is non-cash and does not affect operations or cash flow. But it signals that the goodwill embedded in the balance sheet may require further write-downs if the stock does not recover.

The 10.3% dividend yield is covered by free cash flow today but depends on continued FCF generation. A recession, tariff escalation, or margin collapse could force a cut.

The question is not whether Conagra is a good company. It is a $12 billion revenue company selling household-name frozen foods and snacks to every grocery store in America. The question is whether the market is right to price it for permanent impairment.

Bear case (40% probability): The leveraged grind. Inflation stays elevated. Tariff costs can't be fully passed through without losing the value-tier consumer. The new CEO inherits a portfolio where the premium frozen brands are deteriorating and the growth brands aren't big enough to move the needle. The dividend gets cut to accelerate deleveraging. The stock trades to $10-11.

Base case (40% probability): The slow re-rate. Brase stabilizes operations. Q4 FY26 confirms the organic inflection. Margins recover to 12% as tariff mitigation kicks in. The dividend is maintained. Over 12-18 months the stock re-rates from 8.5x to 10-11x P/E, reaching $16-18. Total return including dividends: 30-45%.

Bull case (20% probability): The Smucker playbook. Brase brings the portfolio-optimization discipline that worked at Smucker: divest more non-core brands, invest in frozen and snacking, and accelerate the transition from "legacy food conglomerate" to "focused frozen and snack platform." The stock re-rates to peer multiples (12-14x P/E), reaching $20-25. Total return including dividends: 60-100%.

Now ($13.56): You are buying a 10.3% dividend yield, 8.5x forward earnings, and a frozen/snack portfolio that just posted its first positive organic quarter in over a year. The balance sheet is heavy ($7.3B net debt, 3.83x leverage) and the CEO hasn't started yet. The risk/reward is asymmetric if you believe the frozen share gains are real: you collect 10% in dividends while waiting for the re-rate, and the downside is cushioned by the dividend floor.

Next catalyst — July 9, 2026 (Q4 FY26 earnings): This is the first quarter under John Brase. The company has guided for positive organic growth, margin inflection to the high end of 11.0-11.5%, and the benefit of a 53rd week. If Q4 confirms the Q3 inflection and Brase articulates a clear strategic vision, the re-rate begins. If Q4 disappoints, the thesis breaks and the stock has no floor above $10.

Decider date — July 9, 2026: The first print under new management. The number that matters is organic net sales growth. Positive = the inflection is confirmed and the re-rate runway is open. Negative = the Q3 number was promotional noise and the market's permanent-impairment pricing is correct.

On July 9, Conagra reports Q4 FY26 earnings — the first full quarter under John Brase as CEO. This is the first chance to see whether the organic inflection (+2.4% in Q3) is a trend or a blip, whether frozen share gains persist without heavy promotional support, and whether the new CEO signals continuity or a strategic pivot.

Turnaround Radar will publish the follow-up analysis within 24 hours of the print, including: updated volume-share data by brand, margin trajectory versus the 12% exit-rate guide, any dividend commentary, and Brase's first public statement on portfolio strategy.

July 9 is the date. Subscribe to get the read.

See the Investment Council's verdict on $CAG → Investment Council: CAG: pending →

All current verdicts: The Verdict Board →

Turnaround Radar · Issue 30 · May 29, 2026

Author: Turnaround Radar